Flaw in mass testing, BP chief weighs in on o...

US tech stocks plunged over worries that the blue wave could slow down the AI boom, and the FT’s Joe Miller explains what stance a Democratic Congress may take towards AI. Plus, the UK government is preparing to extend Palantir’s controversial £330mn health contract, Paraguay’s p ...  Show more

Washington will have trouble getting things done with a gridlocked government after this week’s midterm elections, but it’s hard to tell whether US President Donald Trump will use the defeat as a chance to soften his foreign policy stance. Plus, investors are feeling optimistic a ...  Show more

By the end of last year, if you needed a coronavirus test, you could get one. But when vaccines arrived, focus shifted.

Many of the vaccinated felt like they didn’t need tests and demand took a nosedive. Testing sites were closed or converted into vaccination sites. And ...

The sudden rescinding of zero-covid strictures has, as expected, led to a spike in cases. Our correspondent visits overstretched hospitals and crematoria, and considers what will happen <a href="https://www.economist.com/finance-and-economics/2023/01/02/what-the-great-reopenin ...

The sudden rescinding of zero-covid strictures has, as expected, led to a spike in cases. Our correspondent visits overstretched hospitals and crematoria, and considers what will happen <a href="https://www.economist.com/finance-and-economics/2023/01/02/what-the-great-reopenin ...